moxifloxacin has been researched along with thiolactomycin in 1 studies
Studies (moxifloxacin) | Trials (moxifloxacin) | Recent Studies (post-2010) (moxifloxacin) | Studies (thiolactomycin) | Trials (thiolactomycin) | Recent Studies (post-2010) (thiolactomycin) |
---|---|---|---|---|---|
3,157 | 552 | 1,690 | 99 | 0 | 19 |
Protein | Taxonomy | moxifloxacin (IC50) | thiolactomycin (IC50) |
---|---|---|---|
DNA-(apurinic or apyrimidinic site) endonuclease | Homo sapiens (human) | 1 | |
3-oxoacyl-[acyl-carrier-protein] synthase 3 | Mycobacterium tuberculosis H37Rv | 4 | |
3-oxoacyl-[acyl-carrier-protein] synthase 2 | Mycobacterium tuberculosis H37Rv | 6 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chibale, K; Franzblau, SG; Gut, J; Hans, RH; Rosenthal, PJ; van Helden, PD; Wan, B; Wiid, IJ | 1 |
1 other study(ies) available for moxifloxacin and thiolactomycin
Article | Year |
---|---|
Novel thiolactone-isatin hybrids as potential antimalarial and antitubercular agents.
Topics: Animals; Antimalarials; Antitubercular Agents; Isatin; Lactones; Mycobacterium tuberculosis; Plasmodium falciparum; Structure-Activity Relationship | 2011 |